Loading...
Loading...
Inflammation and clotting markers that predict heart attack risk
Advanced cardiovascular risk testing goes beyond cholesterol to measure inflammatory markers (hsCRP, Lp-PLA2, MPO), clotting factors (fibrinogen, homocysteine), and vascular health markers (ADMA, TMAO) that drive atherosclerosis and thrombosis.
Cholesterol is a weak predictor of heart attack risk. Inflammation, endothelial dysfunction, and hypercoagulability are the real drivers. Half of all heart attacks occur in people with normal cholesterol. This panel reveals the hidden risk factors conventional cardiology ignores.
Heart disease is an inflammatory disease, not a cholesterol disease. A patient with low hsCRP and healthy endothelial function has low risk even with high cholesterol. Conversely, a patient with high hsCRP, elevated homocysteine, and sky-high Lp-PLA2 is at serious risk even with 'good' cholesterol. Gabriel uses cardiovascular risk markers to identify true risk and to design targeted anti-inflammatory, methylation-supporting, and endothelial-healing protocols that address root causes.
A fasting blood draw at a local lab. Fast for 10–12 hours (water only). Results arrive in 3–5 business days with inflammatory and clotting marker analysis. Upload to Gabriel for cardiovascular risk assessment and heart-protective protocols.
Conventional practitioners read these results through a disease-focused lens — looking for what's broken. Gabriel reads them through a naturopathic lens — looking for what's out of balance and how to restore it. We see optimal ranges, not just "normal" ranges. We connect findings across all your diagnostics to reveal patterns that siloed specialists miss.
$200–$400